The downward migration of soil heavy metal(loid)s (HMs) at smelting sites poses a significant risk to groundwater. Therefore, it is requisite for pollution control to determine the pollution characteristics of soil HMs and their migration risks to groundwater. 198 soil samples collected from a Pb-Zn smelting site were classified into 6 clusters by self-organizing map (SOM) and K-means clustering. Cd, Zn, As, and Pb were identified as the characteristic contaminants of the site. The driving factors for the heterogeneous distribution of HMs have been validated through the implementation of K-means clustering and multiple-hits calculation. Using ultrafiltration extraction and microscopic analysis, the soil colloids were identified as crucial carriers facilitating the migration of HMs. Specifically, the colloidal fractions of Cd, Zn, and As, Pb in deep soil (3-4 m) accounted for 91 %, 78 %, 88 %, and 82 %, respectively, consistently surpassing those found in topsoil (0-0.5 m). It was primarily attributed to the strong affinity of HMs toward soil colloids (franklinite, PbS, and kaolinite) and dissolved organic matter (humic acids and protein). The research findings highlight the potential risk of colloidal HMs to groundwater contamination, providing valuable insights for the development of targeted management and remediation strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.scitotenv.2024.174944 | DOI Listing |
J Comp Eff Res
January 2025
Advanz Pharma, London, UK.
Compared with uncomplicated urinary tract infections (UTIs), complicated UTIs (cUTIs) including acute pyelonephritis (AP) present with significant morbidity, a higher risk of treatment failure and typically require longer courses of treatment, or alternative antibiotics. The emergence of drug-resistant organisms represents a considerable challenge in the treatment of patients with cUTIs/AP and has limited antibiotic options. Carbapenems are considered the current last line of therapy, however, carbapenem resistance represents a growing problem.
View Article and Find Full Text PDFCrit Care Explor
January 2025
Department of Mathematics and School of Biomedical Engineering, Colorado State University, Fort Collins, CO.
The purpose of this work is to evaluate the feasibility of lung imaging using 3D electrical impedance tomography (EIT) during spontaneous breathing trials (SBTs) in patients with acute hypoxic respiratory failure. EIT is a noninvasive, nonionizing, real-time functional imaging technique, suitable for bedside monitoring in critically ill patients. EIT data were collected in 24 mechanically ventilated patients immediately preceding and during a SBT on two rows of 16 electrodes using a simultaneous multicurrent source EIT system for 3D imaging.
View Article and Find Full Text PDFJ Viral Hepat
February 2025
Statistics, Modelling and Economics Department, UK Health Security Agency, London, UK.
Chronic hepatitis C virus (HCV) infection is associated with significant morbidity, mortality and health economic burden. Over 90% of HCV cases in England occur in people who inject drugs (PWID). Current treatments for HCV are effective but do not protect against reinfection.
View Article and Find Full Text PDFInfect Dis Poverty
January 2025
School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Background: Hemorrhagic fever with renal syndrome (HFRS) is a climate-sensitive zoonotic disease that poses a significant public health burden worldwide. While previous studies have established associations between meteorological factors and HFRS incidence, there remains a critical knowledge gap regarding the heterogeneity of these effects across diverse epidemic regions. Addressing this gap is essential for developing region-specific prevention and control strategies.
View Article and Find Full Text PDFRespir Med
January 2025
Hospital Costa del Sol, (Málaga), Marbella, Spain. Electronic address:
Background: The ORBE II study showed the real-world effectiveness of benralizumab in severe eosinophilic asthma (SEA). This subgroup analysis aimed to characterize patients and outcomes based on baseline blood eosinophil count (BEC) and/or fractional exhaled nitric oxide (FeNO) levels.
Methods: In this analysis of the ORBE II retrospective study, SEA patients receiving benralizumab were categorized into subgroups based on individual or combined BEC/FeNO levels, according to the following thresholds: high BEC (hiBEC): ≥300 cells/μL; low BEC (loBEC): <300 cells/μL; high FeNO (hiFeNO): ≥50 ppb; low FeNO (loFeNO): <50 ppb.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!